Literature DB >> 18651640

Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid.

Ben Coomber1, Michael F O'Donoghue, Robert Mason.   

Abstract

The endogenous cannabinoid system regulates neuronal excitability. The effects of inhibiting fatty acid amide hydrolase (FAAH), the enzyme responsible for metabolism of the endocannabinoid anandamide, on kainic acid (KA)-induced neuronal activity were investigated in the rat in vivo, using the selective FAAH inhibitor URB597. Hippocampal neuronal ensemble unit activity was recorded in isoflurane-anesthetized rats using 16-wire microelectrode arrays. Separate groups of rats were administered with single doses of KA alone, KA and URB597 (0.3 or 1 mg kg(-1), i.p.), or URB597 (1 mg kg(-1)) alone. The role of the cannabinoid CB1 receptor in mediating the effects of URB597 was explored using the CB1 selective antagonists AM251, either alone or prior to KA and URB597 (1 mg kg(-1)) administration, and SR141716A, administered prior to KA and URB597 (1 mg kg(-1)). Neuronal firing and burst firing rates were examined in animals with confirmed dorsal hippocampal placements. KA induced an increase in both firing and burst firing rates, effects which were attenuated by URB597 in a dose-related manner. Pretreatment with AM251 or SR141716A partly attenuated the URB597-mediated effects on firing and burst firing rate. Rats treated with AM251 or URB597 alone did not exhibit any significant change in either firing or burst firing rates compared with basal activity. These results suggest that the inhibition of endocannabinoid metabolism can suppress hyperexcitability in the rat hippocampus, partly via a CB1 receptor-mediated mechanism. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651640     DOI: 10.1002/syn.20547

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  17 in total

1.  Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.

Authors:  Vinogran Naidoo; David A Karanian; Subramanian K Vadivel; Johnathan R Locklear; JodiAnne T Wood; Mahmoud Nasr; Pamela Marie P Quizon; Emily E Graves; Vidyanand Shukla; Alexandros Makriyannis; Ben A Bahr
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

2.  Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Authors:  Iryna A Khasabova; Sergey Khasabov; Justin Paz; Catherine Harding-Rose; Donald A Simone; Virginia S Seybold
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

3.  THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.

Authors:  David D Aguilar; Andrea Giuffrida; Daniel J Lodge
Journal:  J Psychopharmacol       Date:  2015-10-28       Impact factor: 4.153

4.  Epileptiform activity in the CA1 region of the hippocampus becomes refractory to attenuation by cannabinoids in part because of endogenous γ-aminobutyric acid type B receptor activity.

Authors:  Ricka D Messer; Eric S Levine
Journal:  J Neurosci Res       Date:  2012-03-02       Impact factor: 4.164

5.  Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus.

Authors:  Anushka V Goonawardena; John Sesay; Cheryl Ann Sexton; Gernot Riedel; Robert E Hampson
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

Review 6.  Endocannabinoids and traumatic brain injury.

Authors:  Esther Shohami; Ayelet Cohen-Yeshurun; Lital Magid; Merav Algali; Raphael Mechoulam
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

7.  A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity.

Authors:  Vinogran Naidoo; Spyros P Nikas; David A Karanian; Jeannie Hwang; Jianhong Zhao; JodiAnne T Wood; Shakiru O Alapafuja; Subramanian K Vadivel; David Butler; Alexandros Makriyannis; Ben A Bahr
Journal:  J Mol Neurosci       Date:  2010-11-11       Impact factor: 3.444

8.  Cannabinoid receptor activation reverses kainate-induced synchronized population burst firing in rat hippocampus.

Authors:  Rob Mason; Joseph F Cheer
Journal:  Front Integr Neurosci       Date:  2009-06-15

Review 9.  Molecular Targets of Cannabidiol in Neurological Disorders.

Authors:  Clementino Ibeas Bih; Tong Chen; Alistair V W Nunn; Michaël Bazelot; Mark Dallas; Benjamin J Whalley
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

10.  Temporal characterization of changes in hippocampal cannabinoid CB(1) receptor expression following pilocarpine-induced status epilepticus.

Authors:  Katherine W Falenski; Dawn S Carter; Anne J Harrison; Billy R Martin; Robert E Blair; Robert J DeLorenzo
Journal:  Brain Res       Date:  2009-01-31       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.